{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:42Z","timestamp":1786990302488,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.humpath.2020.07.008","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T12:23:03Z","timestamp":1594988583000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-7332","authenticated-orcid":false,"given":"Michelle D.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A.","family":"DeLellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3666-2546","authenticated-orcid":false,"given":"Lori A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Natu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-8222","authenticated-orcid":false,"given":"Tony","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja R.","family":"Seethala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-1967","authenticated-orcid":false,"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.07.008_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-9-34","article-title":"Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence","volume":"9","author":"Merlin","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.humpath.2020.07.008_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2020.07.008_bib3","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2020.07.008_bib4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.surg.2014.08.069","article-title":"Parathyroid carcinoma in more than 1,000 patients: a population-level analysis","volume":"156","author":"Sadler","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.07.008_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/edrv-3-2-218","article-title":"Parathyroid carcinoma: a review of 62 patients","volume":"3","author":"Shane","year":"1982","journal-title":"Endocr Rev"},{"key":"10.1016\/j.humpath.2020.07.008_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03347413","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity","volume":"30","author":"Agha","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.humpath.2020.07.008_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.07.008_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the genetic basis of parathyroid carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMp038159","article-title":"HRPT2, a marker of parathyroid cancer","volume":"349","author":"Weinstein","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2020.07.008_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejrad.2017.07.026","article-title":"The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma","volume":"95","author":"Christakis","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.humpath.2020.07.008_bib11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jamcollsurg.2014.10.007","article-title":"Modern experience with aggressive parathyroid tumors in a high-volume New England referral center","volume":"220","author":"Quinn","year":"2015","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.humpath.2020.07.008_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/bjs.5570","article-title":"Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma","volume":"94","author":"Ippolito","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.humpath.2020.07.008_bib13","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Udelsman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2020.07.008_bib14","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","article-title":"Clinical presentation, staging and long-term evolution of parathyroid cancer","volume":"17","author":"Talat","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2020.07.008_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/000313480607200511","article-title":"Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma","volume":"72","author":"Chang","year":"2006","journal-title":"Am Surg"},{"key":"10.1016\/j.humpath.2020.07.008_bib16","series-title":"WHO classification of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.humpath.2020.07.008_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/00000478-199308000-00007","article-title":"Histopathological variables and DNA cytometry in parathyroid carcinoma","volume":"17","author":"Bondeson","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib18","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2020.07.008_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hed.22908","article-title":"Parathyroid cancer: outcome analysis of 16 patients treated at the Princess Margaret Hospital","volume":"35","author":"Erovic","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2020.07.008_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/hupa.2003.55","article-title":"Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis","volume":"34","author":"Stojadinovic","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.surg.2015.06.022","article-title":"The clinical importance of parathyroid atypia: is long-term surveillance necessary?","volume":"158","author":"McCoy","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.07.008_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.07.008_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<378::AID-CNCR3>3.0.CO;2-F","article-title":"Parathyroid carcinoma: a diagnostic and therapeutic challenge","volume":"86","author":"Shaha","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.07.008_bib24","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1245\/s10434-012-2306-6","article-title":"Classification of parathyroid cancer","volume":"19","author":"Schulte","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2020.07.008_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/EP:16:1:049","article-title":"Proposal for the histological classification of parathyroid carcinoma","volume":"16","author":"Kameyama","year":"2005","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib26","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.humpath.2020.07.008_bib27","article-title":"Prognostic scoring system to risk stratify parathyroid carcinoma","volume":"15","author":"Silva-Figueroa","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.humpath.2020.07.008_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7150\/jca.2.532","article-title":"Parathyroid carcinoma: a review with three illustrative cases","volume":"2","author":"Digonnet","year":"2011","journal-title":"J Cancer"},{"key":"10.1016\/j.humpath.2020.07.008_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.surg.2008.08.030","article-title":"Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma","volume":"144","author":"Yip","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.07.008_bib30","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.surg.2014.08.005","article-title":"Is central lymph node dissection necessary for parathyroid carcinoma?","volume":"156","author":"Hsu","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2020.07.008_bib31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.07.008_bib32","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.humpath.2020.07.008_bib33","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","article-title":"Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer","volume":"38","author":"Truran","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.humpath.2020.07.008_bib34","article-title":"Novel HRPT2\/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.humpath.2020.07.008_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol"},{"key":"10.1016\/j.humpath.2020.07.008_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.21716","article-title":"Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2020.07.008_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1445-5994.2011.02545.x","article-title":"Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy","volume":"41","author":"Lim","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.humpath.2020.07.008_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.07.008_bib40","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","article-title":"Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma","volume":"94","author":"Howell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2020.07.008_bib42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2020.07.008_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00423-015-1361-4","article-title":"Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism","volume":"401","author":"Ozolins","year":"2016","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.humpath.2020.07.008_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02738728","article-title":"Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas","volume":"6","author":"Lloyd","year":"1995","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0002-9440(10)64086-2","article-title":"Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas","volume":"158","author":"Hemmer","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2020.07.008_bib46","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2020.07.008_bib47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.surg.2014.05.014","article-title":"Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study","volume":"156","author":"Villar-del-Moral","year":"2014","journal-title":"Surgery"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:34Z","timestamp":1758645514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":47,"alternative-id":["S0046817720301313"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.07.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}